{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:21:22Z","timestamp":1793190082447,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH F32 EY029567"],"award-info":[{"award-number":["NIH F32 EY029567"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30 EY026877"],"award-info":[{"award-number":["P30 EY026877"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30 EY026877"],"award-info":[{"award-number":["P30 EY026877"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recently, we established silicone oil-induced ocular hypertension (SOHU) mouse model with significant glaucomatous neurodegeneration. Here we characterize two additional variations of this model that simulate two distinct glaucoma types. The first is a chronic model produced by high frequency (HF) pupillary dilation after SO-induced pupillary block, which shows sustained moderate IOP elevation and corresponding slow, mild glaucomatous neurodegeneration. We also demonstrate that although SO removal quickly returns IOP to normal, the glaucomatous neurodegeneration continues to advance to a similar degree as in the HF group without SO removal. The second, an acute model created by no pupillary dilation (ND), shows a greatly elevated IOP and severe inner retina degeneration at an early time point. Therefore, by a straightforward dilation scheme, we extend our original SOHU model to recapitulate phenotypes of two major glaucoma forms, which will be invaluable for selecting neuroprotectants and elucidating their molecular mechanisms.<\/jats:p>","DOI":"10.1038\/s41598-021-88690-x","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T10:13:30Z","timestamp":1619518410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Chronic mild and acute severe glaucomatous neurodegeneration derived from silicone oil-induced ocular hypertension"],"prefix":"10.1038","volume":"11","author":[{"given":"Fang","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoliang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah C.","family":"Webber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roopa","family":"Dalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,27]]},"reference":[{"key":"88690_CR1","first-page":"774","volume":"36","author":"HA Quigley","year":"1995","unstructured":"Quigley, H. A. et al. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest. Ophthalmol. Vis. Sci. 36, 774\u2013786 (1995).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"88690_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1371\/journal.pgen.0010004","volume":"1","author":"RT Libby","year":"2005","unstructured":"Libby, R. T. et al. Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet. 1, 17\u201326 (2005).","journal-title":"PLoS Genet."},{"key":"88690_CR3","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1083\/jcb.200706181","volume":"179","author":"GR Howell","year":"2007","unstructured":"Howell, G. R. et al. Axons of retinal ganglion cells are insulted in the optic nerve early in DBA\/2J glaucoma. J. Cell Biol. 179, 1523\u20131537 (2007).","journal-title":"J. Cell Biol."},{"key":"88690_CR4","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/S0140-6736(04)16257-0","volume":"363","author":"RN Weinreb","year":"2004","unstructured":"Weinreb, R. N. & Khaw, P. T. Primary open-angle glaucoma. Lancet 363, 1711\u20131720 (2004).","journal-title":"Lancet"},{"key":"88690_CR5","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.preteyeres.2012.07.001","volume":"31","author":"DJ Calkins","year":"2012","unstructured":"Calkins, D. J. Critical pathogenic events underlying progression of neurodegeneration in glaucoma. Prog. Retin. Eye Res. 31, 702\u2013719 (2012).","journal-title":"Prog. Retin. Eye Res."},{"key":"88690_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1146\/annurev.neuro.051508.135728","volume":"35","author":"RW Nickells","year":"2012","unstructured":"Nickells, R. W. et al. Under pressure: cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy. Annu. Rev. Neurosci. 35, 153\u2013179 (2012).","journal-title":"Annu. Rev. Neurosci."},{"key":"88690_CR7","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/S0140-6736(17)31469-1","volume":"390","author":"JB Jonas","year":"2017","unstructured":"Jonas, J. B. et al. Glaucoma. Lancet 390, 2183\u20132193 (2017).","journal-title":"Lancet"},{"key":"88690_CR8","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham, Y. C. et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 121, 2081\u20132090 (2014).","journal-title":"Ophthalmology"},{"key":"88690_CR9","doi-asserted-by":"publisher","first-page":"16067","DOI":"10.1038\/nrdp.2016.67","volume":"2","author":"RN Weinreb","year":"2016","unstructured":"Weinreb, R. N. et al. Primary open-angle glaucoma. Nat. Rev. Dis. Primers 2, 16067 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"88690_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/ICU.0000000000000644","volume":"31","author":"J Iyer","year":"2020","unstructured":"Iyer, J. et al. Toward a new definition of glaucomatous optic neuropathy for clinical research. Curr. Opin. Ophthalmol. 31, 85\u201390 (2020).","journal-title":"Curr. Opin. Ophthalmol."},{"key":"88690_CR11","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/09286580500180572","volume":"12","author":"M Mafwiri","year":"2005","unstructured":"Mafwiri, M. et al. Primary open-angle glaucoma presentation at a tertiary unit in Africa: intraocular pressure levels and visual status. Ophthalmic Epidemiol. 12, 299\u2013302 (2005).","journal-title":"Ophthalmic Epidemiol."},{"key":"88690_CR12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.exer.2010.09.005","volume":"93","author":"CF Burgoyne","year":"2011","unstructured":"Burgoyne, C. F. A biomechanical paradigm for axonal insult within the optic nerve head in aging and glaucoma. Exp. Eye Res. 93, 120\u2013132 (2011).","journal-title":"Exp. Eye Res."},{"key":"88690_CR13","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","volume":"120","author":"A Heijl","year":"2002","unstructured":"Heijl, A. et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch. Ophthalmol. 120, 1268\u20131279 (2002).","journal-title":"Arch. Ophthalmol."},{"key":"88690_CR14","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/S0140-6736(14)62111-5","volume":"385","author":"DF Garway-Heath","year":"2015","unstructured":"Garway-Heath, D. F. et al. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet 385, 1295\u20131304 (2015).","journal-title":"Lancet"},{"key":"88690_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/00055735-200304000-00006","volume":"14","author":"DR Anderson","year":"2003","unstructured":"Anderson, D. R. & Normal Tension Glaucoma, S. Collaborative normal tension glaucoma study. Curr. Opin. Ophthalmol. 14, 86\u201390 (2003).","journal-title":"Curr. Opin. Ophthalmol."},{"key":"88690_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41433-019-0687-5","volume":"34","author":"R Wormald","year":"2020","unstructured":"Wormald, R., Virgili, G. & Azuara-Blanco, A. Systematic reviews and randomised controlled trials on open angle glaucoma. Eye (Lond.) 34, 161\u2013167 (2020).","journal-title":"Eye (Lond.)"},{"key":"88690_CR17","doi-asserted-by":"crossref","unstructured":"Smith RS. Systematic evaluation of the mouse eye: anatomy, pathology, and biomethods. ed). CRC Press (2002).","DOI":"10.1201\/9781420041606"},{"key":"88690_CR18","doi-asserted-by":"publisher","first-page":"100799","DOI":"10.1016\/j.preteyeres.2019.100799","volume":"75","author":"IH Pang","year":"2019","unstructured":"Pang, I. H. & Clark, A. F. Inducible rodent models of glaucoma. Prog. Retin. Eye Res. 75, 100799 (2019).","journal-title":"Prog. Retin. Eye Res."},{"key":"88690_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1167\/iovs.09-3947","volume":"51","author":"RM Sappington","year":"2010","unstructured":"Sappington, R. M. et al. The microbead occlusion model: a paradigm for induced ocular hypertension in rats and mice. Invest. Ophthalmol. Vis. Sci. 51, 207\u2013216 (2010).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"88690_CR20","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.45881","author":"J Zhang","year":"2019","unstructured":"Zhang, J. et al. Silicone oil-induced ocular hypertension and glaucomatous neurodegeneration in mouse. Elife https:\/\/doi.org\/10.7554\/eLife.45881 (2019).","journal-title":"Elife"},{"key":"88690_CR21","doi-asserted-by":"publisher","DOI":"10.3791\/60409","author":"J Zhang","year":"2019","unstructured":"Zhang, J. et al. A reversible silicon oil-induced ocular hypertension model in mice. J. Vis. Exp. https:\/\/doi.org\/10.3791\/60409 (2019).","journal-title":"J. Vis. Exp."},{"key":"88690_CR22","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s00417-009-1155-x","volume":"247","author":"P Ichhpujani","year":"2009","unstructured":"Ichhpujani, P., Jindal, A. & Jay Katz, L. Silicone oil induced glaucoma: a review. Graefe\u2019s Arch. Clin. Exp. Ophthalmol. 247, 1585\u20131593 (2009).","journal-title":"Graefe's Arch. Clin. Exp. Ophthalmol."},{"key":"88690_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/ICU.0000000000000238","volume":"27","author":"HL Kornmann","year":"2016","unstructured":"Kornmann, H. L. & Gedde, S. J. Glaucoma management after vitreoretinal surgeries. Curr. Opin. Ophthalmol. 27, 125\u2013131 (2016).","journal-title":"Curr. Opin. Ophthalmol."},{"key":"88690_CR24","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.4103\/1673-5374.276330","volume":"15","author":"J Zhang","year":"2020","unstructured":"Zhang, J. & Hu, Y. Comparing silicone oil-induced ocular hypertension with other inducible glaucoma models in mice. Neural Regen. Res. 15, 1652\u20131653 (2020).","journal-title":"Neural Regen. Res."},{"key":"88690_CR25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fncel.2020.00109","volume":"14","author":"L Li","year":"2020","unstructured":"Li, L. et al. Longitudinal morphological and functional assessment of RGC neurodegeneration after optic nerve crush in mouse. Front. Cell. Neurosci. 14, 109 (2020).","journal-title":"Front. Cell. Neurosci."},{"key":"88690_CR26","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1167\/iovs.09-4098","volume":"51","author":"JM Kwong","year":"2010","unstructured":"Kwong, J. M., Caprioli, J. & Piri, N. RNA binding protein with multiple splicing: a new marker for retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 51, 1052\u20131058 (2010).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"88690_CR27","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1002\/cne.23521","volume":"522","author":"AR Rodriguez","year":"2014","unstructured":"Rodriguez, A. R., de Sevilla Muller, L. P. & Brecha, N. C. The RNA binding protein RBPMS is a selective marker of ganglion cells in the mammalian retina. J. Comp. Neurol. 522, 1411\u20131443 (2014).","journal-title":"J. Comp. Neurol."},{"key":"88690_CR28","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1167\/iovs.14-13943","volume":"55","author":"TH Chou","year":"2014","unstructured":"Chou, T. H. et al. Robust mouse pattern electroretinograms derived simultaneously from each eye using a common snout electrode. Invest. Ophthalmol. Vis. Sci. 55, 2469\u20132475 (2014).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"88690_CR29","doi-asserted-by":"publisher","first-page":"8754","DOI":"10.1167\/iovs.10-6654","volume":"52","author":"N Nakano","year":"2011","unstructured":"Nakano, N. et al. Longitudinal and simultaneous imaging of retinal ganglion cells and inner retinal layers in a mouse model of glaucoma induced by N-methyl-D-aspartate. Invest. Ophthalmol. Vis. Sci. 52, 8754\u20138762 (2011).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"88690_CR30","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1523\/JNEUROSCI.0102-20.2020","volume":"40","author":"Q Wang","year":"2020","unstructured":"Wang, Q. et al. Mouse gamma-synuclein promoter-mediated gene expression and editing in mammalian retinal ganglion cells. J. Neurosci. 40, 3896\u20133914 (2020).","journal-title":"J. Neurosci."},{"key":"88690_CR31","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.exer.2015.05.008","volume":"141","author":"V Porciatti","year":"2015","unstructured":"Porciatti, V. Electrophysiological assessment of retinal ganglion cell function. Exp. Eye Res. 141, 164\u2013170 (2015).","journal-title":"Exp. Eye Res."},{"key":"88690_CR32","first-page":"224","volume":"14","author":"M Mozaffarieh","year":"2008","unstructured":"Mozaffarieh, M., Grieshaber, M. C. & Flammer, J. Oxygen and blood flow: players in the pathogenesis of glaucoma. Mol. Vis. 14, 224\u2013233 (2008).","journal-title":"Mol. Vis."},{"key":"88690_CR33","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3389\/fcell.2020.00452","volume":"8","author":"LK Wareham","year":"2020","unstructured":"Wareham, L. K. & Calkins, D. J. The Neurovascular Unit in Glaucomatous Neurodegeneration. Front. Cell Dev. Biol. 8, 452 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"88690_CR34","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S1350-9462(02)00008-3","volume":"21","author":"J Flammer","year":"2002","unstructured":"Flammer, J. et al. The impact of ocular blood flow in glaucoma. Prog. Retin. Eye Res. 21, 359\u2013393 (2002).","journal-title":"Prog. Retin. Eye Res."},{"key":"88690_CR35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.preteyeres.2003.12.001","volume":"23","author":"NN Osborne","year":"2004","unstructured":"Osborne, N. N. et al. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog. Retin. Eye Res. 23, 91\u2013147 (2004).","journal-title":"Prog. Retin. Eye Res."},{"issue":"1038\u20131044","key":"88690_CR36","first-page":"e1032","volume":"155","author":"RD Patel","year":"2013","unstructured":"Patel, R. D. et al. Characterization of ischemic index using ultra-widefield fluorescein angiography in patients with focal and diffuse recalcitrant diabetic macular edema. Am. J. Ophthalmol. 155(1038\u20131044), e1032 (2013).","journal-title":"Am. J. Ophthalmol."},{"key":"88690_CR37","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1136\/bjophthalmol-2011-300774","volume":"96","author":"MM Wessel","year":"2012","unstructured":"Wessel, M. M. et al. Peripheral retinal ischaemia, as evaluated by ultra-widefield fluorescein angiography, is associated with diabetic macular oedema. Br. J. Ophthalmol. 96, 694\u2013698 (2012).","journal-title":"Br. J. Ophthalmol."},{"key":"88690_CR38","doi-asserted-by":"publisher","first-page":"18601","DOI":"10.1038\/s41598-020-75576-7","volume":"10","author":"X Cao","year":"2020","unstructured":"Cao, X. et al. Effects of high-fat diet and Apoe deficiency on retinal structure and function in mice. Sci. Rep. 10, 18601 (2020).","journal-title":"Sci. Rep."},{"key":"88690_CR39","unstructured":"Mahabadi N, Foris LA, Tripathy K. Open Angle Glaucoma. In: StatPearls (ed). Treasure Island (FL) (2020)."},{"key":"88690_CR40","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1056\/NEJMicm1712742","volume":"378","author":"H Pohl","year":"2018","unstructured":"Pohl, H. & Tarnutzer, A. A. Acute angle-closure glaucoma. N. Engl. J. Med. 378, e14 (2018).","journal-title":"N. Engl. J. Med."},{"key":"88690_CR41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.preteyeres.2019.01.001","volume":"70","author":"DY Yu","year":"2019","unstructured":"Yu, D. Y. et al. Retinal capillary perfusion: Spatial and temporal heterogeneity. Prog. Retin. Eye Res. 70, 23\u201354 (2019).","journal-title":"Prog. Retin. Eye Res."},{"key":"88690_CR42","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0002-9394(52)90266-3","volume":"35","author":"GG Smith","year":"1952","unstructured":"Smith, G. G. & Baird, C. D. Survival time of retinal cells when deprived of their blood supply by increased intraocular pressure. Am. J. Ophthalmol. 35, 133\u2013136 (1952).","journal-title":"Am. J. Ophthalmol."},{"key":"88690_CR43","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1159\/000310240","volume":"203","author":"ER Buchi","year":"1991","unstructured":"Buchi, E. R., Suivaizdis, I. & Fu, J. Pressure-induced retinal ischemia in rats: an experimental model for quantitative study. Ophthalmologica 203, 138\u2013147 (1991).","journal-title":"Ophthalmologica"},{"key":"88690_CR44","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/0014-4835(91)90215-Z","volume":"53","author":"WF Hughes","year":"1991","unstructured":"Hughes, W. F. Quantitation of ischemic damage in the rat retina. Exp. Eye Res. 53, 573\u2013582 (1991).","journal-title":"Exp. Eye Res."},{"key":"88690_CR45","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1167\/iovs.09-4603","volume":"51","author":"G Chidlow","year":"2010","unstructured":"Chidlow, G. et al. Spatiotemporal characterization of optic nerve degeneration after chronic hypoperfusion in the rat. Invest. Ophthalmol. Vis. Sci. 51, 1483\u20131497 (2010).","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88690-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88690-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88690-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T07:31:04Z","timestamp":1670052664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88690-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,27]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["88690"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-88690-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,27]]},"assertion":[{"value":"4 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9052"}}